Patents by Inventor Jayana Pankajkumar LINESWALA

Jayana Pankajkumar LINESWALA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ATR antagonists and uses thereof
    Patent number: 12122750
    Abstract: This invention provides certain piperidine compounds as AT2R antagonists, e.g., compounds of formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, and X are as defined herein, pharmaceutical compositions thereof, and methods of using the same to treat pain associated with AT2R activity.
    Type: Grant
    Filed: May 11, 2023
    Date of Patent: October 22, 2024
    Assignee: Eli Lilly and Company
    Inventors: Thomas James Beauchamp, Zhaogen Chen, Scott Eugene Conner, Jon Andre Erickson, Maria Cristina Garcia Paredes, Jayana Pankajkumar Lineswala, Emanuele Sher, Bishnu Thapa, Leonard Larry Winneroski
  • AT2R ANTAGONISTS AND USES THEREOF
    Publication number: 20230373919
    Abstract: This invention provides certain piperidine compounds as AT2R antagonists, e.g., compounds of formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, and X are as defined herein, pharmaceutical compositions thereof, and methods of using the same to treat pain associated with AT2R activity.
    Type: Application
    Filed: May 11, 2023
    Publication date: November 23, 2023
    Inventors: Thomas James BEAUCHAMP, Zhaogen CHEN, Scott Eugene CONNER, Jon Andre ERICKSON, Maria Cristina GARCIA PAREDES, Jayana Pankajkumar LINESWALA, Emanuele SHER, Bishnu THAPA, Leonard Larry WINNEROSKI, II
  • 6-METHOXY-3,4-DIHYDRO-1H-ISOQUINOLIN COMPOUNDS
    Publication number: 20230373927
    Abstract: In an embodiment, the present invention provides a compound of the formula: wherein R1 is selected from the group consisting of F and H; R2 is selected from the group consisting of CH3, CH3CHCH3 and —NHCH2CH(CH3)2; R3 is selected from the group consisting of H and —CH2OCH3; R4 is selected from the group consisting of H and CH3; R5 is selected from the group consisting of H and CH3; R6 is selected from the group consisting of H and OH; R7 is selected from the group consisting of or a pharmaceutically acceptable salt thereof, and methods of using this compound for positive allosteric modulation of a receptor selected from the group consisting of GLP1, GIP, and glucagon.
    Type: Application
    Filed: October 6, 2021
    Publication date: November 23, 2023
    Inventors: Ana Belén BUENO MELENDO, Jayana Pankajkumar LINESWALA, Gema RUANO PLAZA, Nuria Diaz BUEZO